8. Huntington disease Clinical trials / Disease details


Clinical trials : 229 Drugs : 193 - (DrugBank : 60) / Drug target genes : 84 - Drug target pathways : 158

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03764215
(ClinicalTrials.gov)
November 15, 201827/11/2018Nilotinib in Huntington's DiseaseAn Open Label, Phase Ib Study to Evaluate the Impact of Low Doses of Nilotinib Treatment on Safety, Tolerability and Biomarkers in Huntington's DiseaseHuntington DiseaseDrug: Nilotinib 150 MGGeorgetown UniversityNULLRecruiting25 Years90 YearsAll10Phase 1United States